Biomarkers – News and Features

An overabundance of cloned white blood cells hampers the immune system and increases the risk of melanoma, a new study finds.

A study found that individuals with depression have a brain network, the frontostriatal salience network, nearly twice as large as those without depression. This enlargement is stable over time and could serve as a biomarker for early diagnosis.

Researchers have developed a noninvasive technique that could dramatically improve the way doctors monitor intracranial hypertension, a condition where increased pressure in the brain can lead to severe outcomes like strokes and hemorrhages.

Researchers have identified altered blood protein levels in individuals with severe periodontitis, including reduced EGF and OLR-1 proteins. These findings offer potential biomarkers for predicting and treating the disease.

A new blood biomarker – potassium isotopes – offers a unique and promising avenue for diagnosing Alzheimer's disease earlier.

Engineers have developed an electronic finger wrap that monitors vital chemical levels – such as glucose, vitamins, and even drugs – present in the same fingertip sweat from which it derives its energy.

New research may provide a new biological target for immunotherapies designed to destroy spreading cancer cells that are often markers for worsening disease.

A new study reveals that hormone therapy (HT) affects biological aging in postmenopausal women. Starting HT before age 45 accelerates aging, while starting after age 45 slows it down.

A new study introduces an advanced cortisol detector using iridium oxide nanoparticles, enhancing stability and sensitivity. This low-cost, high-performance device accurately measures cortisol levels at home.

New research shows potential for DNA methylation, an epigenetic marker, in understanding how genetics and lifestyle factors influence dementia risk.